Japan, Feb. 18 -- NEUTROLIS INC has got intellectual property rights for 'ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY.' Other related details are as follows:

Application Number: JP,2024-133817

Category (FI): A61K35/12,A61K38/38,A61K38/46,A61K47/60,A61K47/64,A61K48/00,A61P1/16,A61P1/18,A61P11/00,A61P13/12,A61P17/02,A61P27/02,A61P29/00,A61P3/00,A61P35/00,A61P37/02,A61P7/00,A61P7/02,A61P9/00,A61P9/10,C12N1/15,C12N1/19,C12N1/21,C12N15/55,C12N15/63@Z,C12N5/10,C12N9/16@Z

Stage: Grant (IP right granted following substantive examination.)

Filing Date: Aug. 9, 2024

Publication Date: Nov. 13, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication....